Nuvectis Pharma NVCT - Options Chain | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Nuvectis Pharma Inc (NVCT)
Nuvectis Pharma Inc (NVCT) Options

Nuvectis Pharma Inc (NVCT)

5.87

0.06

( 1.03% )

Updated: 01:41:54

Delayed by 15 minutes

NVCT Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NMHINatures Miracle Holding Inc	US$ 3.2299 (185.83%)	82.98M
AIFFFirefly Neuroscience Inc	US$ 4.7999 (152.63%)	68.89M
HEESH and E Equipment Services Inc	US$ 90.52 (106.01%)	3.74M
ERNAEterna Therapeutics Inc	US$ 0.6343 (105.28%)	111.8M
TDUPThredUp Inc	US$ 2.00 (53.85%)	2.64M
PHIOPhio Pharmaceuticals Corporation	US$ 4.1301 (-37.42%)	5.33M
ATPCAgape ATP Corporation	US$ 1.36 (-30.96%)	574.98k
MBIOMustang Bio Inc	US$ 0.1659 (-25.90%)	5.21M
AEHRAehr Test Systems	US$ 11.96 (-25.20%)	1.62M
AVGRAvinger Inc	US$ 0.6066 (-24.47%)	700.51k
ERNAEterna Therapeutics Inc	US$ 0.6343 (105.28%)	111.8M
NMHINatures Miracle Holding Inc	US$ 3.2299 (185.83%)	82.98M
AIFFFirefly Neuroscience Inc	US$ 4.7999 (152.63%)	68.89M
PIIIP3 Partners Inc	US$ 0.2585 (20.29%)	57.14M
RGTIRigetti Computing Inc	US$ 7.735 (27.85%)	55.2M

gail

gail 2 months ago

grabbed some on the dip

Monksdream

Monksdream 4 months ago

Monksdream

Monksdream 6 months ago

Monksdream

Monksdream 9 months ago

Monksdream

Monksdream 10 months ago

NVCT 10Q due March 6

Monksdream

Monksdream 1 year ago

conix

conix 3 years ago

NVCT HIGHLIGHTS:

*Recently completed Initial Public Offering - $5.00 Per share
*2 Precision Cancer medicines in development - ovarian and triple negative breast
*Data flow throughout 2022
*CEO with multiple success stories in life science sector to $billion dollar market caps
*Analysts project a $66 billion precision medicines market for 2021; In 6 years, this number is expected to top $140 billion

Nuvectis Pharma Inc - Company Background:

Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for serious conditions of unmet medical need in oncology. The Company is currently developing two drug candidates: NXP800, a clinical-stage HSF1 pathway inhibitor currently in a Phase 1 study in patients with advanced solid tumors, and NXP900, a novel SRC/YES1 kinase inhibitor currently in preclinical development with IND-enabling studies ongoing.

Market Capitalization: $225 million
Range - 52 week: $3.08 - $20.75
Current Price: $20.44
Trades on: Nasdaq Capital Market
Ticker Symbol: NVCT

website: nuvectis.com

TheFinalCD

TheFinalCD 3 years ago

wow from $3 to almost $21

ipo_dude

ipo_dude 3 years ago

TheFinalCD

TheFinalCD 3 years ago

WOW $7 MOVE 3-10

CONGRAT$ NVCT

spindog

spindog 3 years ago

I feel the same

kkballa

kkballa 3 years ago

Nuvectis Pharma

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions